59.00GBp-0.34%Mkt Cap: 269.90M $P/E: 29.501d ago
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and poi…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap269.90M $
Enterprise Value247.46M $
Revenue (TTM)52.93M $
Gross Profit36.63M $
Net Income (TTM)7.61M $
Revenue/Share0.1283 USD
Last Price59.00 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees97
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)29.50
P/E (Forward)14.78
PEG—
EV/EBITDA15.92
EV/Revenue4.67
P/S5.10
P/B3.64
EPS (TTM)0.02
EPS (Forward)0.04
52W Range
53.8422% of range77.60
52W High77.60 GBp
52W Low53.84 GBp
Profitability
Gross Margin69.20%
Oper. Margin20.85%
EBITDA Margin29.36%
Profit Margin14.37%
ROE10.36%
ROA9.19%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF16.74M $
CapEx (TTM)1.63M $
FCF Margin22.36%
FCF Yield4.38%
Net Debt-20.54M $
Net Debt/EBITDA-1.32
Balance Sheet
Debt/Equity0.01
Current Ratio3.81
Quick Ratio3.12
Book Value/Sh0.1620 GBp
Cash/Share0.0480 GBp
Dividends
Fwd Div Rate0.0200 GBp
Trail. Div Rate0.0160 GBp
Div. Yield2.62%
5Y Avg Yield—
Payout Ratio76.22%
Ex-Div DateMay 21, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)81.20 GBp
Upside (mean)+37.6%
Target Range77.00 GBp – 86.00 GBp
GBp77.00+37.6% to meanGBp86.00
# Analysts5
Ownership
Shares Out.420.87M
Float329.25M
Insiders20.93%
Institutions65.78%
Technical
SMA 5059.08 (-0.1%)
SMA 20064.23 (-8.1%)
Beta-0.09
S&P 52W Chg20.25%
Avg Vol (30d)767.11K
Avg Vol (10d)774.34K
Technical Indicators
RSI (14)52.3
MACD-0.1127
MACD Signal-0.3084
MACD Hist.+0.1957
BB Upper60.16 GBp
BB Middle58.02 GBp
BB Lower55.88 GBp
BB Width7.39%
ATR (14)2.816 GBp
Vol Ratio (20d)0.28x